Hebei Changshan Biochem Pharma (300255) — Free Cash Flow Generation Index
Hebei Changshan Biochem Pharma (300255) has a Free Cash Flow Generation Index of 0.73x as of June 2025. Free cash flow of CN¥51.58 Million represents 1% of operating cash flow (CN¥70.22 Million). Explore reinvestment intensity of Hebei Changshan Biochem Pharma to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Hebei Changshan Biochem Pharma Free Cash Flow Generation Index (2009–2024)
Historical FCF Generation Index trend for Hebei Changshan Biochem Pharma across 10 annual periods. For the full cash flow conversion analysis, see Hebei Changshan Biochem Pharma (300255) cash flow conversion.
Annual Free Cash Flow Generation for Hebei Changshan Biochem Pharma (2009–2024)
Year-by-year Free Cash Flow Generation Index for Hebei Changshan Biochem Pharma. Check 300255 cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (CNY) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2024 | -3.26x | CN¥-183.37 Million | CN¥56.22 Million | CN¥239.59 Million | ▲ +46.5% |
| 2023 | -6.10x | CN¥-205.60 Million | CN¥33.73 Million | CN¥239.32 Million | ▲ +95.5% |
| 2022 | -136.97x | CN¥-428.10 Million | CN¥3.13 Million | CN¥431.22 Million | ▼ -28.9% |
| 2021 | -106.29x | CN¥-305.21 Million | CN¥2.87 Million | CN¥308.08 Million | ▼ -53794.8% |
| 2018 | 0.20x | CN¥57.96 Million | CN¥292.81 Million | CN¥234.85 Million | ▲ +707.9% |
| 2017 | 0.02x | CN¥3.98 Million | CN¥162.28 Million | CN¥158.30 Million | ▼ -94.4% |
| 2016 | 0.44x | CN¥75.44 Million | CN¥171.96 Million | CN¥96.52 Million | ▲ +155.9% |
| 2011 | -0.79x | CN¥-13.38 Million | CN¥17.04 Million | CN¥30.43 Million | ▼ -176.3% |
| 2010 | -0.28x | CN¥-8.31 Million | CN¥29.25 Million | CN¥37.56 Million | ▼ -4424.2% |
| 2009 | 0.01x | CN¥159.12K | CN¥24.21 Million | CN¥24.05 Million | — |